HEADER NEUROPEPTIDE 28-JUN-22 8DHZ TITLE NMR STRUCTURE OF AC-HGAL(17-30)NH2, AN N-TERMINALLY ACETYLATED TITLE 2 FRAGMENT OF THE C-TERMINUS OF HUMAN GALANIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALANIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL RESIDUES, 49-62; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS FRAGMENT, NEUROPEPTIDE EXPDTA SOLUTION NMR NUMMDL 25 AUTHOR K.N.KRAICHELY,C.M.HENDY,S.PARNHAM,M.W.GIULIANO REVDAT 2 07-SEP-22 8DHZ 1 JRNL REVDAT 1 24-AUG-22 8DHZ 0 JRNL AUTH R.E.WILKINSON,K.N.KRAICHELY,C.M.HENDY,L.E.BUCHANAN, JRNL AUTH 2 S.PARNHAM,M.W.GIULIANO JRNL TITL THE NEUROPEPTIDE GALANIN ADOPTS AN IRREGULAR SECONDARY JRNL TITL 2 STRUCTURE. JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 626 121 2022 JRNL REFN ESSN 1090-2104 JRNL PMID 35994823 JRNL DOI 10.1016/J.BBRC.2022.08.032 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8DHZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1000266559. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 4.6 REMARK 210 IONIC STRENGTH : SAMPLE WAS DISSOLVED IN 10 MM REMARK 210 SODIUM ACETATE-D3/ACETIC ACID-D4 REMARK 210 BUFFER AT PH 4.6; NO ADDITIONAL REMARK 210 ADDITIVES WERE PRESENT. REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 2 MM AC-HGAL(17-30)-NH2, 4.14 MM REMARK 210 [U-2H] SODIUM ACETATE, 5.86 MM REMARK 210 [U-2H] ACETIC ACID, 95% H2O/5% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 1D 1H NMR; 2D COSY; 2D TOCSY; 2D REMARK 210 ROESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE II REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CNS, MESTRELAB (MNOVA / REMARK 210 MESTRENOVA / MESTREC) REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 25 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 3 -54.82 -122.13 REMARK 500 1 PHE A 7 33.07 -150.56 REMARK 500 2 ASN A 3 -54.90 -122.32 REMARK 500 2 PHE A 7 33.25 -151.27 REMARK 500 2 ASN A 11 -39.78 -136.89 REMARK 500 3 ASN A 3 -54.85 -121.98 REMARK 500 3 PHE A 7 32.95 -150.70 REMARK 500 4 ASN A 3 -56.88 -123.05 REMARK 500 4 PHE A 7 33.29 -151.53 REMARK 500 5 ASN A 3 -54.72 -122.01 REMARK 500 5 PHE A 7 33.19 -151.21 REMARK 500 6 ASN A 3 -56.86 -123.03 REMARK 500 6 PHE A 7 33.23 -150.82 REMARK 500 7 ASN A 3 -56.82 -123.17 REMARK 500 7 PHE A 7 33.26 -151.57 REMARK 500 7 THR A 14 -45.98 -135.82 REMARK 500 8 ASN A 3 -54.66 -121.98 REMARK 500 8 PHE A 7 33.36 -151.39 REMARK 500 9 ASN A 3 -56.86 -123.22 REMARK 500 9 PHE A 7 33.27 -151.55 REMARK 500 10 ASN A 3 -56.69 -123.34 REMARK 500 10 PHE A 7 33.38 -152.08 REMARK 500 10 LYS A 10 -43.21 -135.25 REMARK 500 11 ASN A 3 -54.57 -122.02 REMARK 500 11 PHE A 7 33.26 -151.69 REMARK 500 12 ASN A 3 -57.01 -122.89 REMARK 500 12 PHE A 7 33.15 -151.91 REMARK 500 13 ASN A 3 -56.85 -123.09 REMARK 500 13 PHE A 7 33.43 -151.68 REMARK 500 14 ASN A 3 -56.86 -123.16 REMARK 500 14 PHE A 7 33.33 -151.18 REMARK 500 15 ASN A 3 -56.81 -123.15 REMARK 500 15 PHE A 7 33.16 -151.41 REMARK 500 16 ASN A 3 -57.10 -123.29 REMARK 500 16 PHE A 7 33.38 -152.08 REMARK 500 17 ASN A 3 -56.81 -123.17 REMARK 500 17 PHE A 7 33.24 -151.68 REMARK 500 18 ASN A 3 -56.88 -123.11 REMARK 500 18 PHE A 7 33.27 -151.58 REMARK 500 19 ASN A 3 -54.74 -121.91 REMARK 500 19 PHE A 7 33.36 -151.30 REMARK 500 20 ASN A 3 -57.01 -123.22 REMARK 500 20 PHE A 7 33.36 -151.57 REMARK 500 21 ASN A 3 -56.84 -123.57 REMARK 500 21 PHE A 7 33.29 -151.39 REMARK 500 21 LYS A 10 -43.91 -130.31 REMARK 500 21 ASN A 11 -42.32 -130.50 REMARK 500 22 ASN A 3 -54.36 -122.03 REMARK 500 22 PHE A 7 33.20 -151.15 REMARK 500 23 ASN A 3 -56.89 -123.26 REMARK 500 REMARK 500 THIS ENTRY HAS 56 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7S3O RELATED DB: PDB REMARK 900 GALANIN N-TERMINAL FRAGMENT NMR STRUCTURE REMARK 900 RELATED ID: 34906 RELATED DB: BMRB REMARK 900 GALANIN N-TERMINAL FRAGMENT NMR CHEMICAL SHIFTS REMARK 900 RELATED ID: 7S3Q RELATED DB: PDB REMARK 900 GALANIN N-TERMINAL FRAGMENT NMR STRUCTURE REMARK 900 RELATED ID: 34907 RELATED DB: BMRB REMARK 900 GALANIN N-TERMINAL FRAGMENT NMR CHEMICAL SHIFTS REMARK 900 RELATED ID: 7S3R RELATED DB: PDB REMARK 900 GALANIN N-TERMINAL FRAGMENT NMR STRUCTURE REMARK 900 RELATED ID: 34908 RELATED DB: BMRB REMARK 900 GALANIN N-TERMINAL FRAGMENT NMR CHEMICAL SHIFTS REMARK 900 RELATED ID: 8DJ4 RELATED DB: PDB REMARK 900 DEPOSITION IN PROGRESS - FULL LENGTH GALANIN NMR STRUCTURE REMARK 900 RELATED ID: 31032 RELATED DB: BMRB REMARK 900 DEPOSITION IN PROGRESS - FULL LENGTH GALANIN NMR CHEMICAL SHIFTS REMARK 900 RELATED ID: 31029 RELATED DB: BMRB REMARK 900 NMR STRUCTURE OF AC-HGAL(17-30)NH2, AN N-TERMINALLY ACETYLATED REMARK 900 FRAGMENT OF THE C-TERMINUS OF HUMAN GALANIN. DBREF 8DHZ A 2 15 UNP P22466 GALA_HUMAN 49 62 SEQADV 8DHZ ACE A 1 UNP P22466 ACETYLATION SEQADV 8DHZ NH2 A 16 UNP P22466 AMIDATION SEQRES 1 A 16 ACE GLY ASN HIS ARG SER PHE SER ASP LYS ASN GLY LEU SEQRES 2 A 16 THR SER NH2 HET ACE A 1 6 HET NH2 A 16 3 HETNAM ACE ACETYL GROUP HETNAM NH2 AMINO GROUP FORMUL 1 ACE C2 H4 O FORMUL 1 NH2 H2 N LINK C ACE A 1 N GLY A 2 1555 1555 1.34 LINK C SER A 15 N NH2 A 16 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 HETATM 1 C ACE A 1 9.571 5.943 6.408 1.00 4.84 C HETATM 2 O ACE A 1 10.446 6.696 5.964 1.00 5.00 O HETATM 3 CH3 ACE A 1 8.291 6.503 6.965 1.00 5.84 C HETATM 4 H1 ACE A 1 7.522 5.742 6.899 1.00 6.11 H HETATM 5 H2 ACE A 1 7.996 7.360 6.391 1.00 6.28 H HETATM 6 H3 ACE A 1 8.461 6.799 7.995 1.00 6.14 H